AAAAAA
Results:
1-16
|
Results: 16
Authors:
de Bruijn, P
Kehrer, DFS
Verweij, J
Sparreboom, A
Citation: P. De Bruijn et al., Liquid chromatographic determination of ketoconazole, a potent inhibitor of CYP3A4-mediated metabolism, J CHROMAT B, 753(2), 2001, pp. 395-400
Authors:
Kehrer, DFS
Sparreboom, A
Verweij, J
de Bruijn, P
Nierop, CA
van de Schraaf, J
Ruijgrok, EJ
de Jonge, MJA
Citation: Dfs. Kehrer et al., Modulation of irinotecan-induced diarrhea by cotreatment with neomycin in cancer patients, CLIN CANC R, 7(5), 2001, pp. 1136-1141
Authors:
Yamamoto, W
Verweij, J
de Bruijn, P
de Jonge, MJA
Takano, H
Nishiyama, M
Kurihara, M
Sparreboom, A
Citation: W. Yamamoto et al., Active transepithelial transport of irinotecan (CPT-11) and its metabolites by human intestinal Caco-2 cells, ANTI-CANC D, 12(5), 2001, pp. 419-432
Authors:
van Zuylen, L
Karlsson, MO
Verweij, J
Brouwer, E
de Bruijn, P
Nooter, K
Stoter, G
Sparreboom, A
Citation: L. Van Zuylen et al., Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles, CANC CHEMOT, 47(4), 2001, pp. 309-318
Authors:
Loos, WJ
Kehrer, D
Brouwer, E
Verweij, J
de Bruijn, P
Hamilton, M
Gill, S
Nooter, K
Stoter, G
Sparreboom, A
Citation: Wj. Loos et al., Liposomal lurtotecan (NX211): determination of total drug levels in human plasma and urine by reversed-phase high-performance liquid chromatography, J CHROMAT B, 738(1), 2000, pp. 155-163
Authors:
Kehrer, DFS
Yamamoto, W
Verweij, J
de Jonge, MJA
de Bruijn, P
Sparreboom, A
Citation: Dfs. Kehrer et al., Factors involved in prolongation of the terminal disposition phase of SN-38: Clinical and experimental studies, CLIN CANC R, 6(9), 2000, pp. 3451-3458
Authors:
Loos, WJ
de Bruijn, P
Verweij, J
Sparreboom, A
Citation: Wj. Loos et al., Determination of camptothecin analogs in biological matrices by high-performance liquid chromatography, ANTI-CANC D, 11(5), 2000, pp. 315-324
Authors:
de Jonge, MJA
Verweij, J
de Bruijn, P
Brouwer, E
Mathijssen, RHJ
van Alphen, RJ
de Boer-Dennert, MM
Vernillet, L
Jacques, C
Sparreboom, A
Citation: Mja. De Jonge et al., Pharmacokinetic, metabolic, and pharmacodynamic profiles in a dose-escalating study of irinotecan and cisplatin, J CL ONCOL, 18(1), 2000, pp. 195-203
Authors:
Loos, WJ
de Bruijn, P
van Zuylen, L
Verweij, J
Nooter, K
Stoter, G
Sparreboom, A
Citation: Wj. Loos et al., Determination of 5-fluorouracil in microvolumes of human plasma by solventextraction and high-performance liquid chromatography, J CHROMAT B, 735(2), 1999, pp. 293-297
Authors:
de Jonge, MJA
Verweij, J
Planting, AST
van der Burg, MEL
Stoter, G
de Boer-Dennert, MM
de Bruijn, P
Brouwer, E
Vernillet, L
Sparreboom, A
Citation: Mja. De Jonge et al., Drug-administration sequence does not change pharmacodynamics and kineticsof irinotecan and cisplatin, CLIN CANC R, 5(8), 1999, pp. 2012-2017
Authors:
Sparreboom, A
Planting, AST
Jewell, RC
van der Burg, MEL
van der Gaast, A
de Bruijn, P
Loos, WJ
Nooter, K
Chandler, LH
Paul, EM
Wissel, PS
Verweij, J
Citation: A. Sparreboom et al., Clinical pharmacokinetics of doxorubicin in combination with GF120918, a potent inhibitor of MDR1 P-glycoprotein, ANTI-CANC D, 10(8), 1999, pp. 719-728
Authors:
Mathijssen, RHJ
van Alphen, RJ
de Jonge, MJA
Verweij, J
de Bruijn, P
Loos, WJ
Nooter, K
Vernillet, L
Stoter, G
Sparreboom, A
Citation: Rhj. Mathijssen et al., Sparse-data set analysis for irinotecan and SN-38 pharmacokinetics in cancer patients co-treated with cisplatin, ANTI-CANC D, 10(1), 1999, pp. 9-16
Authors:
Snijders, J
de Bruijn, P
Bergmans, M
Bastianen, G
Citation: J. Snijders et al., Study on causes and prevention of electrostatic charge build-up during extracorporeal circulation, PERFUSION-U, 14(5), 1999, pp. 363-370
Authors:
Sparreboom, A
van Zuylen, L
Brouwer, E
Loos, WJ
de Bruijn, P
Gelderblom, B
Pillay, M
Nooter, K
Stoter, G
Verweij, J
Citation: A. Sparreboom et al., Cremophor EL-mediated alteration of paclitaxel distribution in human blood: Clinical pharmacokinetic implications, CANCER RES, 59(7), 1999, pp. 1454-1457
Authors:
de Bruijn, P
de Jonge, MJA
Verweij, J
Loos, WJ
Nooter, K
Stoter, G
Sparreboom, A
Citation: P. De Bruijn et al., Femtomole quantitation of 7-ethyl-10-hydroxycamptothecine (SN-38) in plasma samples by reversed-phase high-performance liquid chromatography, ANALYT BIOC, 269(1), 1999, pp. 174-178
Authors:
de Bruijn, P
Verweij, J
Loos, WJ
Kolker, HJ
Planting, AST
Nooter, K
Stoter, G
Sparreboom, A
Citation: P. De Bruijn et al., Determination of doxorubicin and doxorubicinol in plasma of cancer patients by high-performance liquid chromatography, ANALYT BIOC, 266(2), 1999, pp. 216-221
Risultati:
1-16
|